Is ProShares - UltraShort Nasdaq Biotechnology (BIS) a Buy, Sell, or Hold?
ProShares - UltraShort Nasdaq Biotechnology
NASDAQ:BIS
$13.7411 USD
$0.13 (0.96%)
- Volume
- 3.86K
- Average Volume
- 8.78K
- Market Capitalization
- $2.46M
- P/E Ratio
- Dividend Yield
- %
- Price Target
- $
- Year High
- $33.14
- Year Low
- $12.37
- Day High
- —
- Day Low
- —
- Payout Ratio
- $
- Current Ratio
- $
| Source | Headline |
|---|---|
|
BIS dares to blaspheme as AI bubble fears wane
Although some deem it blasphemous to suggest the AI boom is another bubble, the world's central banking forum and watchdog has warned against getting swept up in the frenzy, just as investors appear increasingly reluctant to second-guess it. reuters.com - 2026-06-30 02:08:03 |
|
BIS says debt, AI boom and fragilities raise global risks
Global pressures from rising public debt to financial fragilities and the sustainability of the AI boom are increasing risks, underscoring the need for disciplined policymaking, according to the Bank for International Settlements. reuters.com - 2026-06-28 05:03:38 |
|
Powered by Silicon Labs, Comminent Ships 500,000 Wi-SUN Modules
Powered by Silicon Labs, Comminent Ships 500,000 Wi-SUN Modules PR Newswire BENGALURU, India and AUSTIN, Texas, gurufocus.com - 2026-05-21 01:00:00 |
